Anna Falanga
Overview
Explore the profile of Anna Falanga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
225
Citations
7598
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gomez-Rosas P, Nagy M, Spronk H, Russo L, Gamba S, Tartari C, et al.
J Thromb Haemost
. 2025 Mar;
PMID: 40056983
Background: Non-small cell lung cancer (NSCLC) patients are at high risk of venous thromboembolism (VTE), especially during chemotherapy. Even though the contact system is implicated in the pathogenesis of thrombosis,...
2.
Colarusso C, Terlizzi M, Di Caprio S, Falanga A, DAndria E, dEmmanuele di Villa Bianca R, et al.
Biomedicines
. 2025 Feb;
13(2).
PMID: 40002808
Absent in melanoma 2 (AIM2) is a member of the innate immune sensors that recognizes cytosolic nucleic acids, leading to inflammasome assembly. In recent years, several studies in the oncology...
3.
Munoz M, Meier J, Falanga A
Blood Transfus
. 2025 Feb;
23(1):1-4.
PMID: 39977526
No abstract available.
4.
Falanga A, Ambaglio C, Barcella L
Blood Transfus
. 2025 Feb;
23(1):64-69.
PMID: 39977525
No abstract available.
5.
Colarusso C, Terlizzi M, Di Caprio S, Falanga A, DAndria E, dEmmanuele di Villa Bianca R, et al.
Biomedicines
. 2025 Jan;
13(1).
PMID: 39857785
The link between inflammation and cancer has been extensively studied over the years. While the inflammatory process can facilitate tumor establishment and progression, on the other hand, current clinical approaches...
6.
Petito E, Bury L, Antunes Heck L, Sadler B, De Candia E, Podda G, et al.
Br J Haematol
. 2024 Oct;
206(1):290-295.
PMID: 39462764
No risk factors have been identified for vaccine-induced immune thrombotic thrombocytopenia (VITT) so far. The aim of this study was to identify human leucocyte antigen (HLA) alleles potentially associated with...
7.
Van Cutsem E, Mahe I, Felip E, Agnelli G, Awada A, Cohen A, et al.
Eur J Cancer
. 2024 Aug;
209:114263.
PMID: 39128187
Venous thromboembolism (VTE) is a common and potentially life-threatening complication in patients with cancer. Both cancer and its treatments increase the risk of developing VTE. Specific cancer types and individual...
8.
Colarusso C, Falanga A, Di Caprio S, Terlizzi M, DAndria E, Antonio M, et al.
Biomed Pharmacother
. 2024 Jun;
176:116896.
PMID: 38876049
Idiopathic pulmonary fibrosis (IPF) is a severe disability due to progressive lung dysfunction. IPF has long been viewed as a non-immune form of pulmonary fibrosis, but nowadays it is accepted...
9.
Kelliher S, Gamba S, Weiss L, Shen Z, Marchetti M, Schieppati F, et al.
Blood Adv
. 2024 Jun;
8(16):4276-4280.
PMID: 38861353
No abstract available.
10.
Falanga A, Lorusso D, Colombo N, Cormio G, Cosmi B, Scandurra G, et al.
Cancers (Basel)
. 2024 May;
16(9).
PMID: 38730721
The prevention and appropriate management of venous thromboembolism in cancer patients is of paramount importance. However, the literature data report an underestimation of this major problem in patients with gynecological...